Valuation GSK plc

Equities

Market Closed - London S.E. Other stock markets 19:35:19 15/05/2026 +04			5-day change	1st Jan Change
1,862.50 ^GBX	-0.53%		+1.06%	+2.08%

05-15	WINNERS & LOSERS: Miners slide; Centrica to pay GBP20 million to Ofgem	AN
05-14	Morningstar Upgrades GSK to Buy Rating	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Capitalization ¹	80,458	58,381	59,112	54,944	73,201	74,350	-	-
Change	-	-27.44%	1.25%	-7.05%	33.23%	1.57%	-	-
Enterprise Value (EV) ¹	100,296	75,578	74,152	68,039	87,654	86,635	83,755	81,537
Change	-	-24.65%	-1.89%	-8.24%	28.83%	-1.16%	-3.32%	-2.65%
P/E ratio	18.6x	3.93x	11.9x	21.3x	12.9x	11.7x	10.9x	10.8x
PBR	5.34x	5.47x	4.4x	4.02x	-	4.05x	3.32x	2.9x
PEG	-	0x	-0.2x	-0.4x	0x	0.9x	1.47x	7.55x
Capitalization / Revenue	2.36x	1.99x	1.95x	1.75x	2.24x	2.2x	2.1x	2.04x
EV / Revenue	2.94x	2.58x	2.45x	2.17x	2.68x	2.57x	2.37x	2.24x
EV / EBITDA	8.85x	7.23x	6.37x	6.36x	7.77x	7.54x	6.85x	6.54x
EV / EBIT	11.4x	9.27x	8.44x	7.44x	8.96x	8.47x	7.6x	7.06x
EV / FCF	22.6x	12.1x	13.6x	13x	13.7x	15.2x	13.8x	12.3x
FCF Yield	4.42%	8.28%	7.36%	7.67%	7.32%	6.56%	7.24%	8.15%
Dividend per Share ²	1	0.6125	0.58	0.61	0.66	0.6991	0.7325	0.7608
Rate of return	4.98%	4.26%	4%	4.53%	3.62%	3.75%	3.93%	4.08%
EPS ²	1.082	3.662	1.216	0.632	1.411	1.588	1.706	1.73
Distribution rate	92.4%	16.7%	47.7%	96.5%	46.8%	44%	42.9%	44%
Net sales ¹	34,114	29,324	30,328	31,376	32,667	33,747	35,385	36,438
EBITDA ¹	11,330	10,449	11,635	10,693	11,278	11,489	12,221	12,467
EBIT ¹	8,806	8,151	8,786	9,148	9,783	10,229	11,025	11,556
Net income ¹	4,385	14,956	4,928	2,575	5,716	6,297	6,725	6,928
Net Debt ¹	19,838	17,197	15,040	13,095	14,453	12,285	9,405	7,186
Reference price ²	20.08	14.38	14.50	13.46	18.24	18.62	18.62	18.62
Nbr of stocks (in thousands)	4,006,383	4,060,999	4,076,145	4,080,519	4,012,126	3,991,951	-	-
Announcement Date	09/02/22	01/02/23	31/01/24	05/02/25	04/02/26	-	-	-

¹GBP in Million²GBP

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
GSK PLC	11.73x	2.57x	7.54x	3.75%	99.05B
ELI LILLY AND COMPANY	29.49x	10.7x	22.09x	0.68%	896B
JOHNSON & JOHNSON	24.23x	5.59x	15.19x	2.35%	546B
ABBVIE INC.	25.6x	6.33x	12.92x	3.26%	372B
ROCHE HOLDING AG	17.06x	4.28x	10.53x	3.11%	328B
ASTRAZENECA PLC	22.87x	4.75x	13.5x	1.84%	282B
NOVARTIS AG	20.47x	5.52x	13.41x	3.03%	283B
MERCK & CO., INC.	49.69x	4.66x	18.94x	2.99%	275B
NOVO NORDISK A/S	13.55x	4.96x	10.13x	3.73%	206B
AMGEN INC.	21.22x	5.75x	10.04x	3.09%	176B
Average	23.59x	5.51x	13.43x	2.78%	346.24B
Weighted average by Cap.	25.52x	6.60x	15.52x	2.31%